Beclocort (HFA) 250 mcg/puff (Inhaler)

200 metered doses: ৳ 350.00

Medicine Details

Product Title

  • Beclometasone 50, 100 & 250 HFA Inhaler

Categories

  • Medicine
  • Respiratory Products
  • Asthma Management

Description

  • A prophylactic management inhaler for mild, moderate, or severe asthma in adults or children
  • Produces anti-inflammatory action in the lungs with lower incidence and severity of adverse effects compared to systemic corticosteroids
  • Has dose adjustments for adults and children based on severity of disease
  • Provides instructions for proper inhaler administration and cleaning
  • Contraindicated in cases of hypersensitivity to its components or active/quiescent pulmonary tuberculosis
  • May cause systemic effects at high doses, particularly at high doses prescribed for prolonged periods

Dosage Range for Adults

200 - 800 micrograms/day

Dosage Range for Children

50 - 200 micrograms/day

Usual Starting Dose for Adults

200 micrograms twice a day

Usual Starting Dose for Children

100 micrograms twice a day

Indicated Severity Levels

  • Mild asthma
  • Moderate asthma
  • Severe asthma

Pharmacological Effects

  • Produces anti-inflammatory and vasoconstrictor effects

Pharmacological Mechanisms

  • Mechanisms responsible for the anti-inflammatory action are unknown
  • Has a wide range of effects on multiple cell types and mediators involved in inflammation
  • Is a pro-drug with weak glucocorticoid receptor binding affinity

Active Metabolite

Beclomethasone-17-monopropionate (B-17-MP)

Mode of Administration

Oral inhalation use

Proper Inhaler Usage

  • Shake the inhaler vigorously before each use
  • Ensure that the inhaler is used correctly to allow the medicine to reach the lungs
  • Regular usage even when asymptomatic is necessary for optimum benefit
  • Instructions for cleaning the inhaler

Contraindications

  • Hypersensitivity to any components
  • Special caution in patients with active or quiescent pulmonary tuberculosis

Possible Side Effects

  • Cushing's syndrome
  • Adrenal suppression
  • Growth retardation in children and adolescents
  • Decrease in bone mineral density
  • Cataract
  • Glaucoma

Pregnancy & Lactation Safety

  • Inadequate evidence of safety in human pregnancy
  • Potential fetal abnormalities with corticosteroids
  • Benefits vs. hazards weighing required for breastfeeding mothers

Therapeutic Class

  • Respiratory corticosteroids

Storage Conditions

  • Below 30°C
  • Protected from direct sunlight and heat
  • Canister should not be broken, punctured, or burnt
  • Keep away from eyes and out of reach of children

Related Brands